alprazolam has been researched along with Vomiting in 14 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alprazolam, a newer benzodiazepine, may be useful in the control of nausea and vomiting in breast cancer patients." | 9.11 | Alprazolam significantly improves the efficacy of granisetron in the prophylaxis of emesis secondary to moderately emetogenic chemotherapy in patients with breast cancer. ( Abali, H; Guler, N; Oyan, B, 2005) |
| " We have studied the role of a benzodiazepine (alprazolam: A) in addition to granisetron for controlling emesis in patients treated with moderately emetogenic chemotherapy for malignant lymphomas according to an anxiety scale (Covi score)." | 9.09 | Granisetron plus or minus alprazolam for emesis prevention in chemotherapy of lymphomas: a randomized multicenter trial. Granisetron Trialists Group. ( Bauduer, F; Coiffier, B; Desablens, B, 1999) |
| "The usefulness of alprazolam (minor tranquilizer) used in combination with metoclopramide plus methylprednisolone for the prevention and control of emesis induced by chemotherapies, including 5-day continuous intravenous infusion of cisplatin (25 mg/m2/day) for advanced lung cancer, was evaluated using a double-blind randomized crossover design." | 9.07 | Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis. ( Mori, K; Saito, Y; Tominaga, K, 1993) |
| "Usefulness of alprazolam for control of chemotherapy-induced emesis including 5-day continuous intravenous infusion of cisplatin for advanced lung cancer was evaluated by a randomized crossover design." | 9.07 | [Usefulness of alprazolam in controlling cisplatin-induced emesis]. ( Miyazawa, N; Mori, K; Saitoh, Y; Tominaga, K; Yokoi, K, 1991) |
| "To evaluate the efficacy of a combined therapy of prednisolone and alprazolam for controlling cisplatin-induced delayed emesis, a study involving 14 non-small cell lung cancer patients receiving cisplatin (80 mg/m2) was conducted." | 7.68 | [A combined anti-emesis therapy of oral prednisolone and alprazolam for cisplatin-induced delayed emesis]. ( Horio, Y; Iwahara, T; Minami, H; Sakai, S; Shibagaki, T; Shimokata, K; Watanabe, A, 1990) |
| "Alprazolam, a newer benzodiazepine, may be useful in the control of nausea and vomiting in breast cancer patients." | 5.11 | Alprazolam significantly improves the efficacy of granisetron in the prophylaxis of emesis secondary to moderately emetogenic chemotherapy in patients with breast cancer. ( Abali, H; Guler, N; Oyan, B, 2005) |
| " We have studied the role of a benzodiazepine (alprazolam: A) in addition to granisetron for controlling emesis in patients treated with moderately emetogenic chemotherapy for malignant lymphomas according to an anxiety scale (Covi score)." | 5.09 | Granisetron plus or minus alprazolam for emesis prevention in chemotherapy of lymphomas: a randomized multicenter trial. Granisetron Trialists Group. ( Bauduer, F; Coiffier, B; Desablens, B, 1999) |
| "The purpose of our study was to evaluate the effectiveness of alprazolam (APZ) as an adjuvant drug to ondansentron against cisplatin-induced emesis." | 5.07 | Comparison of ondansentron (GR 38032F) versus ondansentron plus alprazolam as antiemetic prophylaxis during cisplatin-containing chemotherapy. ( Bacoyiannis, C; Charalambidis, G; Karabelis, A; Kosmidis, P; Mylonakis, N; Pagou, M; Tsavaris, N, 1994) |
| "The usefulness of alprazolam (minor tranquilizer) used in combination with metoclopramide plus methylprednisolone for the prevention and control of emesis induced by chemotherapies, including 5-day continuous intravenous infusion of cisplatin (25 mg/m2/day) for advanced lung cancer, was evaluated using a double-blind randomized crossover design." | 5.07 | Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis. ( Mori, K; Saito, Y; Tominaga, K, 1993) |
| "Usefulness of alprazolam for control of chemotherapy-induced emesis including 5-day continuous intravenous infusion of cisplatin for advanced lung cancer was evaluated by a randomized crossover design." | 5.07 | [Usefulness of alprazolam in controlling cisplatin-induced emesis]. ( Miyazawa, N; Mori, K; Saitoh, Y; Tominaga, K; Yokoi, K, 1991) |
| "Olanzapine antagonizes multiple receptors and has potential to treat a host of symptoms including nausea, anorexia, anxiety, and insomnia, but healthcare providers should be mindful of potential risks and unclear benefits for off-label indications." | 4.31 | Benefits and risks of off-label olanzapine use for symptom management in cancer patients-a case report. ( Amaram-Davila, JS; Bruera, E; Dev, R; Fortuno, ES; Haider, A, 2023) |
| "To evaluate the efficacy of a combined therapy of prednisolone and alprazolam for controlling cisplatin-induced delayed emesis, a study involving 14 non-small cell lung cancer patients receiving cisplatin (80 mg/m2) was conducted." | 3.68 | [A combined anti-emesis therapy of oral prednisolone and alprazolam for cisplatin-induced delayed emesis]. ( Horio, Y; Iwahara, T; Minami, H; Sakai, S; Shibagaki, T; Shimokata, K; Watanabe, A, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 9 (64.29) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Dev, R | 1 |
| Fortuno, ES | 1 |
| Amaram-Davila, JS | 1 |
| Haider, A | 1 |
| Bruera, E | 1 |
| Abali, H | 1 |
| Oyan, B | 1 |
| Guler, N | 1 |
| Tsavaris, N | 3 |
| Kosmas, C | 1 |
| Kopterides, P | 1 |
| Vadiaka, M | 1 |
| Kosmas, N | 1 |
| Skopelitis, H | 1 |
| Karadima, D | 1 |
| Kolliokosta, G | 1 |
| Tzima, E | 1 |
| Loukeris, D | 1 |
| Pagouni, E | 1 |
| Batziou, E | 1 |
| Xyla, V | 1 |
| Koufos, C | 1 |
| Weltzin, TE | 1 |
| Bulik, CM | 1 |
| McConaha, CW | 1 |
| Kaye, WH | 1 |
| Charalambidis, G | 1 |
| Pagou, M | 1 |
| Karabelis, A | 1 |
| Mylonakis, N | 2 |
| Bacoyiannis, C | 1 |
| Kosmidis, P | 2 |
| Mori, K | 2 |
| Saito, Y | 1 |
| Tominaga, K | 2 |
| Loeb, P | 1 |
| Adnet, P | 1 |
| Boittiaux, P | 1 |
| Forget, AP | 1 |
| Mille, FX | 1 |
| Bauduer, F | 1 |
| Coiffier, B | 1 |
| Desablens, B | 1 |
| Lehoczky, O | 1 |
| Bagaméri, A | 1 |
| Sárosi, Z | 1 |
| Kulcsár, T | 1 |
| Pulay, T | 1 |
| Tsoutsos, H | 1 |
| Bacoyannis, C | 1 |
| Karvounis, N | 1 |
| Kozatsani-Halividi, D | 1 |
| Tsaroucha-Noutsou, E | 1 |
| Klinaki, A | 1 |
| Saitoh, Y | 1 |
| Yokoi, K | 1 |
| Miyazawa, N | 1 |
| Salles, G | 1 |
| Archimbaud, E | 1 |
| Thomas, X | 1 |
| Fiere, D | 1 |
| Watanabe, A | 1 |
| Horio, Y | 1 |
| Minami, H | 1 |
| Shibagaki, T | 1 |
| Iwahara, T | 1 |
| Sakai, S | 1 |
| Shimokata, K | 1 |
| Greenberg, DB | 1 |
| Surman, OS | 1 |
| Clarke, J | 1 |
| Baer, L | 1 |
6 trials available for alprazolam and Vomiting
| Article | Year |
|---|---|
Alprazolam significantly improves the efficacy of granisetron in the prophylaxis of emesis secondary to moderately emetogenic chemotherapy in patients with breast cancer.
Topics: Alprazolam; Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neop | 2005 |
Comparison of ondansentron (GR 38032F) versus ondansentron plus alprazolam as antiemetic prophylaxis during cisplatin-containing chemotherapy.
Topics: Adult; Aged; Alprazolam; Cisplatin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Na | 1994 |
Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis.
Topics: Adult; Aged; Alprazolam; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non | 1993 |
Granisetron plus or minus alprazolam for emesis prevention in chemotherapy of lymphomas: a randomized multicenter trial. Granisetron Trialists Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alprazolam; Anti-Anxiety Agents; Antiemetics; Antineopla | 1999 |
[Usefulness of alprazolam in controlling cisplatin-induced emesis].
Topics: Adult; Aged; Alprazolam; Antiemetics; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Inf | 1991 |
Antiemetic activity of high-dose methylprednisolone associated with continuous-infusion metoclopramide and oral alprazolam during multiple-day chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alprazolam; Antineoplastic Combined Chemotherapy Protoco | 1991 |
8 other studies available for alprazolam and Vomiting
| Article | Year |
|---|---|
Benefits and risks of off-label olanzapine use for symptom management in cancer patients-a case report.
Topics: Adenocarcinoma; Aged; Alprazolam; Anorexia; Antiemetics; Cisplatin; Female; Humans; Male; Middle Age | 2023 |
Efficacy of tropisetron in patients with advanced non-small-cell lung cancer receiving adjuvant chemotherapy with carboplatin and taxanes.
Topics: Aged; Alprazolam; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinom | 2008 |
Laxative withdrawal and anxiety in bulimia nervosa.
Topics: Adult; Alprazolam; Anxiety; Bulimia; Cathartics; Female; Hospitalization; Humans; Substance Withdraw | 1995 |
[Benzodiazepine withdrawal presenting as pseudo-surgical abdominal pain].
Topics: Abdomen, Acute; Adult; Alprazolam; Anti-Anxiety Agents; Bromazepam; Diagnosis, Differential; Headach | 1997 |
[Does the addition of an anxiolytic drug improve the anti-emetic effectiveness of the steroid and granisetron combination in the prophylaxis of cisplatin-induced vomiting?].
Topics: Alprazolam; Anti-Anxiety Agents; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cispla | 2001 |
Antiemetic efficacy of alprazolam in carboplatin-induced emesis.
Topics: Administration, Oral; Aged; Alprazolam; Carboplatin; Drug Therapy, Combination; Female; Humans; Infu | 1991 |
[A combined anti-emesis therapy of oral prednisolone and alprazolam for cisplatin-induced delayed emesis].
Topics: Administration, Oral; Adult; Aged; Alprazolam; Antineoplastic Combined Chemotherapy Protocols; Carci | 1990 |
Alprazolam for phobic nausea and vomiting related to cancer chemotherapy.
Topics: Adult; Alprazolam; Antineoplastic Agents; Female; Humans; Male; Nausea; Placebos; Vomiting | 1987 |